Sponsor Dossier
Jazz Pharmaceuticals
Sponsor Dossier for Jazz Pharmaceuticals. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
About
Jazz Pharmaceuticals is an Australian Private Company with ABN 83 643 560 534, registered in New South Wales. The entity is active and registered for GST.
Portfolio
Jazz Pharmaceuticals has 5 brands on the ARTG, of which 5 are indexable and 5 carry a Product Information document. 2 brands are PBS-listed, 3 have a PBAC outcome on record, and 5 have an AusPAR on record. Notable brands include DEFITELIO, ENRYLAZE, EPIDYOLEX, Sativex, VYXEOS.
Therapeutic focus
— Oncology: 2 brands — Neurology: 2 brands — Haematology: 1 brand
PBS footprint
2 brands are PBS-listed, with the latest PBS schedule date 2026-10-01.
Regulatory activity
The latest PBAC outcome is 2026-03-01, across 3 brands with a PBAC outcome on record. The latest AusPAR is 2025-11-18, across 5 brands with an AusPAR on record.